Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Akebia Therapeutics Q4 Earnings

Akebia Therapeutics (NASDAQ:AKBA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Akebia Therapeutics missed estimated earnings by 21.21%, reporting an EPS of $-0.4 versus an estimate of $-0.33.

Revenue was up $2.91 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 3.62% drop in the share price the next day.

Here's a look at Akebia Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.32 -0.32 -0.36 -0.4
EPS Actual -0.34 -0.51 -0.45 -0.6
Revenue Estimate 49.67M 52.88M 42.84M 51.16M
Revenue Actual 48.76M 52.91M 52.30M 56.70M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.